Bridge Medicines Appoints Louis M. Renzetti, Ph.D., As Chief Scientific Officer

NEW YORK, April 3, 2018 -- (Healthcare Sales & Marketing Network) -- Bridge Medicines, a pioneering drug discovery company focused on advancing promising early technologies from concept to clinic, announced today the appointment of Louis M. Renzetti, Ph.D... Biopharmaceuticals, Personnel Bridge Medicines
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news